• About Us
    • Our Company
    • Our People
  • Our Science
    • Overview
    • Precise Antibody Engineering
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
  • Pipeline
    • Overview
    • MMB101
    • MMB102
    • MFA011
  • Partnering
  • News
  • Contact
  • About Us
    • Our Company
    • Our People
  • Our Science
    • Overview
    • Precise Antibody Engineering
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
  • Pipeline
    • Overview
    • MMB101
    • MMB102
    • MFA011
  • Partnering
  • News

  • Contact

Partnering with Us

MediMabBios business model is focused on open innovation, and we are actively looking for global partners who share our vision and commitment to open innovation.

We are open to explore various collaboration models based on its existing pipeline programs as well as joint research & development opportunities

Contact Us

BD@medimabbio.com

  • Home
  • About Us
    • Our Company
    • Our People
  • Our Science
    • Overview
    • Precise Antibody Engineering
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
  • Pipeline
    • Overview
    • MMB101
    • MMB102
    • MFA011
  • Partnering
  • News
  • Contact

#721, 54, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13449 Tel. 82-(0)31-623-2100 Fax. 82-(0)31-751-2101 Email. info@medimabbio.com

©MEDIMABBIO. ALL RIGHTS RESERVED.